Tea Tree Oil, known for its exceptional antibacterial, antifungal, and antiviral properties, is extracted from the Australian plant Melaleuca alternifolia. However, the effectiveness of this essential oil in traditional supplements is often compromised due to its volatility, which makes it difficult to assimilate. Fortunately, science continues to make significant advances each year, and thanks to ongoing research and experimentation, we now have optimal solutions.

By using the coacervation microencapsulation method, IPS has succeeded in microencapsulating Tea Tree Oil, preserving its active ingredients while enhancing its stability and efficacy.

The microencapsulation of Tea Tree Oil offers numerous advantages for both manufacturers and consumers of supplements. IPS microcapsules, with sizes ranging from 100 to 600 μm, are ideal for incorporation into various formulations, each tailored to a specific use for consumers.

This technology not only protects the volatile active substance but also facilitates its controlled release within the body, thereby maximizing absorption and therapeutic efficacy. For manufacturers, this means the ability to offer more effective products with greater stability, attributes that translate into a significant competitive edge in the market.

Consumers, on the other hand, benefit directly from the increased availability of the oil, improved therapeutic outcomes, and reduced need for frequent dosing. The microencapsulation technology ensures that the oil retains its nutritional properties, providing a natural and powerful aid against issues like cold sores and flu symptoms. This is made possible thanks to the presence of components like terpinen-4-ol and 1,8 cineole, which maintain a very high concentration within the microcapsules (up to 85%).

Thanks to its innovative products and continuous scientific research, IPS stands at the forefront of the supplement industry, promising tangible and lasting benefits for manufacturers and consumers seeking ever higher standards.